It showed that 12.9% of selected high-risk patients with BC had BRCA deleterious mutations, similar to frequencies reported from Lebanon23 but higher than frequencies reported from Qatar.24 In our study, BRCA1 mutations were more common (82.5% of mutations) than BRCA2 mutations, which is similar to the pattern in the Western population, although different from that among Asian populations, in which BRCA2 mutations are more common.2 Here, BRCA1 is linked to breast cancer.